Lipopolysaccharides from campylobacter jejuni O:41 strains associated with guillain-barre syndrome exhibit mimicry of GM1 ganglioside

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3649-3755

  Prendergast, Martina M ^a   Lastovica, Albert J ^b   Moran, Anthony P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; GANGLIOSIDE GM1;

ANTIGEN DETECTION; ARTICLE; CAMPYLOBACTER JEJUNI; CROSS REACTION; EPITOPE MAPPING; GUILLAIN BARRE SYNDROME; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL;

EID: 0031849441     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3649-3655.1998     Document Type: Article

References (70)

1. Aspinall, G. O., C. M. Lynch, H. Pang, R. T. Shaver, and A. P. Moran. 1995. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. Eur. J. Biochem. 231:570-578.
2. Aspinall, G. O., S. Fujimoto, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
3. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19. Structures of the core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33:241-249.
4. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213:1029-1037.
5. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, S. D. Mills, L. A. Kurjanczyk, and J. L. Penner. 1992. Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J. Bacteriol. 174:1324-1332.
6. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, A. P. Moran, and J. L. Penner. 1993. Chemical structure of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213:1017-1027.
7. Ayling, R. D., M. J. Woodward, S. Evans, and D. G. Newell. 1996. Restriction fragment length polymorphism of polymerase chain reaction products applied to the differentiation of poultry Campylobacters for epidemiological investigations. Res. Vet. Sci. 60:168-172.
8. Downs, A., and W. Pigman. 1976. Qualitative and quantitative determination of sialic acids. Methods Carbohydr. Chem. 7:233-240.
9. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
10. Figueras, A., F. J. Morales-Olivas, D. Capella, V. Palop, and T. R. Laporte. 1992. Bovine gangliosides and acute motor polyneuropathy. Br. Med. J. 305: 1330-1331.
11. Fujimoto, S., N. Yuki, T. Itoh, and K. Amako. 1992. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J. Infect. Dis. 165:183. (Letter.)
12. 1H NMR. Biochemistry 30:5032-5038.
13. Gamian, A., E. Romanowska, J. Ulrich, and J. Defaye. 1992. The structure of the sialic acid-containing Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide. Carbohydr. Res. 236: 195-208.
14. Gregson, N. A., S. Koblar, and R. A. C. Hughes. 1993. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q. J. Med. 86:111-117.
15. Griffin, J. W., and T. W. H. Ho. 1993. The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann. Neurol. 34:125-127.
16. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
17. Ho, T. W., B. Mishu, C. Y. Li, C. Y. Gao, D. R. Cornblath, G. W. Griffin, A. K. Asbury, M. J. Blaser, and M. J. McKhann. 1995. Guillain-Barré syndrome in Northern China. Relationship to Campylobacter jejuni infection and antiglycolipid antibodies. Brain 118:597-605.
18. Illa, I., N. Ortiz, E. Gallard, C. Juarez, J. M. Grau, and M. C. Dalakas. 1995. Acute axonal Guillain-Barré syndrome with IgG antibody against motor axons following parenteral gangliosides. Ann. Neurol. 38:218-224.
19. 1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37:260-264.
20. Kaldor, J., and B. R. Speed. 1984. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br. Med. J. 288:1867-1870.
21. Krauss, J. H., K. Himmelspach, G. Reuter, R. Schauer, and H. Mayer. 1992. Structural analysis of a novel sialic acid-containing trisaccharide from Rhodobacter capsulatus 37b4 lipopolysaccharide. Eur. J. Biochem. 204:217-223.
22. Krauss, J. H., G. Reuter, R. Schauer, J. Weckesser, and H. Mayer. 1988. Sialic acid-containing lipopolysaccharide in purple nonsulfur bacteria. Arch. Microbiol. 150:584-589.
23. Kuroki, S., T. Haruta, M. Yoshiota, Y. Kobayashi, M. Nukina, and H. Nakanishi. 1991. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr. Infect. Dis. J. 10:149-151.
24. Kuroki, S., T. Saida, M. Nukina, T. Haruta, M. Yoshiota, Y. Kobayashi, and H. Nakanishi. 1993. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
26. Lastovica, A. J., E. A. Goddard, and A. C. Argent. 1997. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J. Infect. Dis. 176(Suppl. 2):S139-S143.
27. Mishu, B., and M. J. Blaser. 1993. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin. Infect. Dis. 17:104-108.
28. Mishu, B., T. W. Ho, C. Y. Li, C. Y. Gao, J. W. Griffin, A. K. Asbury, D. R. Cornblath, C. M. Patton, G. M. McKhann, and M. J. Blaser 1993. Guillain-Barré syndrome (GBS), acute motor axonal neuropathy and Campylobacter jejuni infection. Acta Gastro-Enterol. Belg. 56(Suppl.):S9.
29. Mishu, B., A. A. Ilyas, C. L. Koski, F. J. Vriesdorp, S. D. Cook, F. A. Milton, and M. J. Blaser. 1993. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 118:947-957.
30. Monos, D. S., M. Papaioakim, T. W. Ho, C. Y. Li, and G. M. McKhann. 1997. Differential distribution of HLA alleles in two forms of Guillain-Barre syndrome. J. Infect. Dis. 176(Suppl. 2):S180-S182.
31. Moran, A. P. 1995. Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures. FEMS Immunol. Med. Microbiol. 11:121-130.
32. Moran, A. P., and T. U. Kosunen. 1989. Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli. APMIS 97:253-260.
33. Moran, A. P., and D. T. O'Malley. 1995. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotoxin Res. 2:233-235.
34. Moran, A. P., D. T. O'Malley, T. U. Kosunen, and I. M. Helander 1994. Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect. Immun. 62:3922-3929.
35. Moran, A. P., and M. M. Prendergast. Unpublished data.
36. Moran, A. P., and C. V. Carroll. Unpublished data.
37. Moran, A. P., M. M. Prendergast, and B. J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharide and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:105-115.
38. Moran, A. P., E. T. Rietschel, T. U. Kosunen, and U. Zahringer. 1991. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173:618-626.
39. Nachamkin, I. Unpublished data.
40. Nikaido, H., and M. Vaara. 1987. Outer membrane, p. 7-22. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimunum: cellular and molecular biology, vol. 1. American Society for Microbiology, Washington, D.C.
41. 1 antibodies. J. Neurol. Sci. 109:200-206.
42. Obayashi, H., T. Saida, S. Kuroki, M. Nukina, and Y. Nishitani. 1993. Guillain-Barré syndrome and Campylobacter jejuni infection. Shinkei Naika 38:431-438.
43. 1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38:170-175.
44. Penner, J. L., and G. O. Aspinall. 1997. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J. Infect. Dis. 176(Suppl. 2):S135-S138.
45. Penner, J. L., J. N. Hennessy, and R. V. Congi. 1983. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin. Microbiol. 2:78-83.
46. Preston, M. A., and J. L. Penner. 1987. Structural and antigenic properties of lipopolysaccharide from serotype reference strains of Campylobacter jejuni. Infect. Immun. 55:1806-1812.
47. Rees, J. H., N. A. Gregson, P. L. Griffiths, and R. A. C. Hughes. 1993. Campylobacter jejuni and Guillain-Barré syndrome. Q. J. Med. 86:623-634.
48. Rees, J. H., and R. A. C. Hughes. 1994. Campylobacter jejuni and Guillain-Barré syndrome. Ann. Neurol. 35:248-249.
49. Rees, J. H., S. E. Soudain, N. A. Gregson, and R. A. C. Hughes. 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1374-1379.
50. Ropper, A. H. 1992. The Guillain-Barré syndrome. N. Engl. J. Med. 326: 1130-1136.
51. Saito, M., N. Kasai, and R. K. Yu. 1985. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148:54-58.
52. 3. Infect. Immun. 64:2945-2949.
53. Schneider, H., T. L. Hale, W. D. Zollinger, R. C. Seid, Jr., C. A. Hammack, and J. M. Griffiss. 1984. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 45:544-549.
54. Schwerer, B., A. Neisser, R. J. Polt, H. Bernheimer, and A. P. Moran. 1995. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotoxin Res. 2:395-403.
55. Schwimmer, S., and A. Bevenue. 1956. Reagent for differentiation of 1,4- and 1,6-linked glucosaccharides. Science 123:543-544.
56. Skirrow, M. B., and J. Benjamin. 1980. Differentiation of enteropathogenic Campylobacter. J. Clin. Pathol. 33:1122.
57. Towbin, H., T. Staehelin, and S. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
58. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
59. van der Meché, F. G. A., P. I. M. Schmitz, and the Dutch Guillain-Barré Study Group. 1992. A randomized trial comparing intravenous globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med. 326:1123-1129.
60. Wassenaar, T. M., N. M. C. Bleumink-Pluym, and B. A. M. van der Zeijst. 1991. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J 10:2055-2061.
61. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-92.
62. Willison, H. J., and P. G. E. Kennedy. 1993. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J. Neuroimmunol. 46:105-112.
63. Yuki, N. 1994. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 17:680-682.
64. Yuki, N., S. Handa, T. Tai, M. Takahashi, K. Saito, Y. Tsujino, and T. Taki. 1995. Ganglioside-like epitopes of lipopolysaccharide from Campylobacter jejuni (Pen 19) in three isolates from patients with Guillain-Barré syndrome. J. Neurol. Sci. 130:112-116.
65. 1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13:451-453.
66. Yuki, N., H. Ichikawa, and A. Doi. 1995. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J. Pediatr. 126:55-57.
67. Yuki, N., S. Sato, T. Itoh, and T. Miyatake. 1991. HLA-B35 and acute axonal polyneuropathy following Campylobacter infection. Neurology 41:1561-1563.
68. 1 ganglioside-like structure. J. Exp. Med. 178:1771-1775.
69. 1a epitope. Infect. Immun. 62:2101-2103.
70. 1 antibodies following Campylobacter enteritis. Neurology 40:1900-1902.